Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lipsitch

Showing results (1-10 of 446) with videos related to

Pageof 45
Sort By:
Health Security|July 27, 2017
If a Global Catastrophic Biological Risk Materializes, at What Stage Will We Recognize It?Marc Lipsitch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Challenges of Vaccine Effectiveness and Waning StudiesMarc Lipsitch
The Lancet. Infectious Diseases|April 4, 2020
Estimating case fatality rates of COVID-19Marc Lipsitch
Science (New York, N.Y.)|January 8, 2005
Ethics of rationing the flu vaccineMarc Lipsitch
European Journal of Epidemiology|June 22, 2020
Good science is good science: we need specialists, not sectsMarc Lipsitch
Mbio|October 16, 2014
Can limited scientific value of potential pandemic pathogen experiments justify the risks?Marc Lipsitch
Journal of Medical Ethics|April 21, 2022
Wrong question and the wrong standard of proofMarc Lipsitch
Applied Biosafety : Journal of the American Biological Safety Association|June 23, 2025
Principal Investigator Responsibility for Flagging Research with Dual-Use or Pandemic RiskMarc Lipsitch
The Journal of Infectious Diseases|August 10, 2016
Comment on "Gain-of-Function Research and the Relevance to Clinical Practice"Marc Lipsitch
Medgenmed : Medscape General Medicine|December 22, 2005
Pandemic flu: we are not preparedMarc Lipsitch
Pageof 45

Showing results (1-10 of 446) with videos related to

Sort By:
Pageof 45
Health Security|July 27, 2017
If a Global Catastrophic Biological Risk Materializes, at What Stage Will We Recognize It?Marc Lipsitch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Challenges of Vaccine Effectiveness and Waning StudiesMarc Lipsitch
The Lancet. Infectious Diseases|April 4, 2020
Estimating case fatality rates of COVID-19Marc Lipsitch
Science (New York, N.Y.)|January 8, 2005
Ethics of rationing the flu vaccineMarc Lipsitch
European Journal of Epidemiology|June 22, 2020
Good science is good science: we need specialists, not sectsMarc Lipsitch
Mbio|October 16, 2014
Can limited scientific value of potential pandemic pathogen experiments justify the risks?Marc Lipsitch
Journal of Medical Ethics|April 21, 2022
Wrong question and the wrong standard of proofMarc Lipsitch
Applied Biosafety : Journal of the American Biological Safety Association|June 23, 2025
Principal Investigator Responsibility for Flagging Research with Dual-Use or Pandemic RiskMarc Lipsitch
The Journal of Infectious Diseases|August 10, 2016
Comment on "Gain-of-Function Research and the Relevance to Clinical Practice"Marc Lipsitch
Medgenmed : Medscape General Medicine|December 22, 2005
Pandemic flu: we are not preparedMarc Lipsitch
Pageof 45